Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer's Disease Progression inCaenorhabditiselegansand Neuronal Cultures
Nikoletta Papaevgeniou, Marianthi Sakellari, Sweta Jha, et al.
Antioxidants and Redox Signaling (2016) Vol. 25, Iss. 16, pp. 855-869
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Javier Egea, Isabel Fabregat, Yves‐Michel Frapart, et al.
Redox Biology (2017) Vol. 13, pp. 94-162
Open Access | Times Cited: 297
Proteostasis, oxidative stress and aging
Ioanna Korovila, Martín Hugo, José Pedro Castro, et al.
Redox Biology (2017) Vol. 13, pp. 550-567
Open Access | Times Cited: 232
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 383-383
Open Access | Times Cited: 202
Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases
Marta Pajares, Antonio Cuadrado, Ana I. Rojo
Redox Biology (2017) Vol. 11, pp. 543-553
Open Access | Times Cited: 191
Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases
Sofia M. Lagoumtzi, Niki Chondrogianni
Free Radical Biology and Medicine (2021) Vol. 171, pp. 169-190
Closed Access | Times Cited: 175
Caenorhabditis elegans: A Convenient In Vivo Model for Assessing the Impact of Food Bioactive Compounds on Obesity, Aging, and Alzheimer's Disease
Peiyi Shen, Yiren Yue, Jolene Zheng, et al.
Annual Review of Food Science and Technology (2017) Vol. 9, Iss. 1, pp. 1-22
Closed Access | Times Cited: 136
Sulforaphane - role in aging and neurodegeneration
Roberto Santín-Márquez, Adriana Alarcón‐Aguilar, Norma Edith López‐Díazguerrero, et al.
GeroScience (2019) Vol. 41, Iss. 5, pp. 655-670
Open Access | Times Cited: 125
Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders
Evert Njomen, Jetze J. Tepe
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 14, pp. 6469-6481
Open Access | Times Cited: 106
Redox regulation of proteasome function
Maria Lefaki, Nikoletta Papaevgeniou, Niki Chondrogianni
Redox Biology (2017) Vol. 13, pp. 452-458
Open Access | Times Cited: 103
Terpenoids as Potential Geroprotectors
Ekaterina Proshkina, Sergey Plyusnin, Tatyana Babak, et al.
Antioxidants (2020) Vol. 9, Iss. 6, pp. 529-529
Open Access | Times Cited: 100
Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging
Efstathios S. Gonos, Μαριάννα Καπετάνου, Jolanta Sereikaitė, et al.
Aging (2018) Vol. 10, Iss. 5, pp. 868-901
Open Access | Times Cited: 93
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 89
Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
Yam Nath Paudel, Efthalia Angelopoulou, Bridgette D. Semple, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 4, pp. 485-500
Closed Access | Times Cited: 74
Modeling Alzheimer’s Disease in Caenorhabditis elegans
Javier Álvarez, Pilar Álvarez-Illera, Jaime Santo‐Domingo, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 288-288
Open Access | Times Cited: 52
Emerging topics in C. elegans aging research: Transcriptional regulation, stress response and epigenetics
Martin S. Denzel, Louis R. Lapierre, Hildegard I. D. Mack
Mechanisms of Ageing and Development (2018) Vol. 177, pp. 4-21
Open Access | Times Cited: 72
Structural basis of the anti-ageing effects of polyphenolics: mitigation of oxidative stress
Adam Rolt, Lynne S. Cox
BMC Chemistry (2020) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Bioactive Phytochemicals with Anti-Aging and Lifespan Extending Potentials in Caenorhabditis elegans
Nkwachukwu Oziamara Okoro, Arome Solomon Odiba, Patience Ogoamaka Osadebe, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7323-7323
Open Access | Times Cited: 45
The ciliary protein RPGRIP1L governs autophagy independently of its proteasome-regulating function at the ciliary base in mouse embryonic fibroblasts
Andreas Struchtrup, Antonia Wiegering, Björn Stork, et al.
Autophagy (2018) Vol. 14, Iss. 4, pp. 567-583
Open Access | Times Cited: 52
Proteasome activation enhances stemness and lifespan of human mesenchymal stem cells
Μαριάννα Καπετάνου, Niki Chondrogianni, Spyros Petrakis, et al.
Free Radical Biology and Medicine (2016) Vol. 103, pp. 226-235
Closed Access | Times Cited: 51
The dietary triterpenoid 18α–Glycyrrhetinic acid protects from MMC-induced genotoxicity through the ERK/Nrf2 pathway
Maria Lefaki, Nikoletta Papaevgeniou, Josep A. Tur, et al.
Redox Biology (2019) Vol. 28, pp. 101317-101317
Open Access | Times Cited: 38
Polygonum multiflorumThunb extract extended the lifespan and healthspan ofCaenorhabditis elegans viaDAF-16/SIR-2.1/SKN-1
Menglu Sun, Xinyan Chen, Jinjin Cao, et al.
Food & Function (2021) Vol. 12, Iss. 18, pp. 8774-8786
Closed Access | Times Cited: 28
Therapeutic Antiaging Strategies
Shailendra Kumar Mishra, Vyshnavy Balendra, Josephine Esposto, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2515-2515
Open Access | Times Cited: 20
Bisphenol-A (BPA) Impairs Hippocampal Neurogenesis via Inhibiting Regulation of the Ubiquitin Proteasomal System
Sangh Jyoti Singh, Ankit Tandon, Phoolmala, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 6, pp. 3277-3298
Closed Access | Times Cited: 13
P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease
Carolina Bianchi, Beatriz Álvarez-Castelao, Álvaro Sebastián‐Serrano, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound
Konstantina Filippopoulou, Nikoletta Papaevgeniou, Maria Lefaki, et al.
Free Radical Biology and Medicine (2016) Vol. 103, pp. 256-267
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top